SCHEMBL13574109

SCHEMBL13574109

COBNCc1ccc(Nc2ncc3cc([Si](C)(C)C)ccc3n2)cc1

nearest known ligand 0.48

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ BRAF P15056 20/20 0.48
▸ RAF1 P04049 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12671175 0.85 BRAF (0.49) BRAFRAF1
SCHEMBL12671174 0.82 BRAF (0.45) BRAFRAF1
SCHEMBL12671537 0.81 BRAF (0.44) BRAFRAF1
SCHEMBL13252021 0.72 CDK4 (0.42) BRAF
SCHEMBL17529301 0.69 BRAF (0.49) BRAF
SCHEMBL13363057 0.67 BRAF (0.48) BRAFRAF1
SCHEMBL13252103 0.66 BRAF (0.46) BRAF
SCHEMBL25880788 0.66 MAP3K5 (0.61) BRAFRAF1
SCHEMBL30512106 0.66 MAP3K5 (0.61) BRAFRAF1
SCHEMBL13225904 0.65 BRAF (0.45) BRAFRAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009153313-A1 2 -ARYLAMINOQUINAZOLINES FOR TREATING PROLIFERATIVE DISEASES NOVARTIS AG (CH) 2009-12-23 — — WO disclosed
Send feedback